ACR-6840

N/A

Report date: 2026/02/24 20:00:16
NMEFirst In Class

Base Information

Drug NameACR-6840
Drug Alias NameACR-6840ACR6840
ClassificationSmall molecules
Mechanisms of ActionCyclin-dependent kinase 19 inhibitors
TargetsCyclin-dependent kinase 19
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesAcrivon Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAcrivon Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A